Dermatology · Overland Park, KS
NPI
1275700528
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11520 West 119th Street
Overland Park, KS, 66213
Phone (913) 232-9372
Groups this clinician bills Medicare through
Medicare paid, 2024
$341K
2,219 services
Medicare patients, 2024
469
Average age 74
Drug cost, 2024
$35K
1,986 prescriptions
Company payments, 2025
$79K
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Meena K Singh was code Q4158 (kerecis omega3, per square centimeter), 273 times for 19 patients. In total Meena K Singh billed 2,219 services in 76 codes, and Medicare paid $341K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q4158 Kerecis omega3, per square centimeter | Office | 273 | 19 | $142.39 | $39K |
| 17311 Mohs Surgery | Office | 237 | 187 | $470.25 | $111K |
| 99213 Office E&M - Established | Office | 182 | 145 | $58.18 | $11K |
| 17003 Destruction Skin Lesion | Office | 174 | 32 | $4.24 | $738 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 137 | 70 | $0.73 | $99.51 |
| 17312 Mohs Surgery | Office | 136 | 93 | $298.70 | $41K |
| 99214 Office E&M - Established | Office | 128 | 104 | $79.82 | $10K |
| 11901 Skin | Office | 95 | 63 | $48.02 | $4,562 |
| 13132 Wound Repair - All Levels | Office | 93 | 80 | $175.99 | $16K |
| 99212 Office E&M - Established | Office | 69 | 67 | $36.33 | $2,507 |
| 12032 Wound Repair - All Levels | Office | 59 | 54 | $124.40 | $7,340 |
| 17000 Destruction Skin Lesion | Office | 58 | 47 | $34.14 | $1,980 |
| 11400 Skin Lesion Excision | Office | 45 | 29 | $64.11 | $2,885 |
| 11102 Skin Biopsy | Office | 39 | 33 | $50.60 | $1,974 |
| 17313 Mohs Surgery | Office | 35 | 35 | $443.04 | $16K |
By year: 2022 $529K for 3,410 services; 2023 $380K for 2,416 services; 2024 $341K for 2,219 services.
Medicare prescription drug claims, 2024
In 2024, the drug Meena K Singh prescribed most often to Medicare patients was Minoxidil, with 785 prescriptions and refills. In total Meena K Singh wrote 1,986 Medicare prescriptions that cost $35K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Minoxidil Generic | 785 | 1,621 | 221 | $7,043 |
| Dutasteride Generic | 375 | 811 | 113 | $10K |
| Doxycycline Hyclate Generic | 164 | 193 | 98 | $2,535 |
| Finasteride Generic | 157 | 369 | 52 | $1,664 |
| Ciprofloxacin Hcl Generic | 77 | 77 | 73 | $385 |
| Spironolactone Generic | 67 | 160 | 24 | $545 |
| Mupirocin Generic | 42 | 42 | 39 | $288 |
| Gentamicin Sulfate Generic | 34 | 34 | 32 | $1,339 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 32 | 37 | 17 | $1,099 |
| Clobetasol Propionate Generic | 31 | 34 | 19 | $1,271 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | 25 | $162 |
| Ketoconazole Generic | 22 | 31 | 11 | $200 |
| Hydrocortisone Generic | 21 | 21 | 13 | $151 |
| Triamcinolone Acetonide Generic | 19 | 21 | 15 | $388 |
| Bicalutamide Generic | 17 | 50 | Under 11 | $255 |
Brand drugs: 12 claims; generic drugs: 1,974 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Meena K Singh $79K ($79K in general payments such as food, travel and fees) from 23 companies. The largest payer was Pfizer Inc. with $39K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 33 | $39K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 38 | $20K |
| Abbvie Inc. ABBV | 39 | $12K |
| Arcutis Biotherapeutics, Inc. ARQT | 22 | $4,877 |
| Revance Therapeutics, Inc. | 3 | $308 |
| Kerecis Limited | 8 | $230 |
| UCB, Inc. UCB.BR | 12 | $187 |
| Amgen Inc. AMGN | 8 | $139 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $129 |
| Organon LLC OGN | 4 | $106 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.